Orion Capital Management LLC Trims Holdings in Edap Tms S.A. (NASDAQ:EDAP)

Orion Capital Management LLC decreased its holdings in Edap Tms S.A. (NASDAQ:EDAP) by 3.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 75,574 shares of the medical equipment provider’s stock after selling 2,300 shares during the quarter. Orion Capital Management LLC owned about 0.20% of Edap Tms worth $399,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Milestone Investment Advisors LLC acquired a new position in Edap Tms in the 3rd quarter valued at $39,000. Summit Trail Advisors LLC acquired a new position in Edap Tms in the 3rd quarter valued at $77,000. Finally, Rock Springs Capital Management LP increased its stake in Edap Tms by 14.6% in the 3rd quarter. Rock Springs Capital Management LP now owns 1,360,000 shares of the medical equipment provider’s stock valued at $9,547,000 after buying an additional 173,700 shares during the period. Hedge funds and other institutional investors own 62.74% of the company’s stock.

Edap Tms Trading Up 1.4 %

EDAP traded up $0.10 on Wednesday, reaching $7.14. 24,431 shares of the company’s stock were exchanged, compared to its average volume of 38,774. The company’s 50 day moving average is $7.27 and its 200-day moving average is $6.28. The company has a market cap of $264.89 million, a price-to-earnings ratio of -11.17 and a beta of 0.74. Edap Tms S.A. has a twelve month low of $3.60 and a twelve month high of $12.23. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.30 and a current ratio of 2.84.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings data on Wednesday, March 27th. The medical equipment provider reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.13). Edap Tms had a negative net margin of 35.03% and a negative return on equity of 34.33%. The firm had revenue of $21.27 million during the quarter, compared to analyst estimates of $21.30 million. Equities analysts predict that Edap Tms S.A. will post -0.31 earnings per share for the current year.

Analysts Set New Price Targets

EDAP has been the topic of several recent research reports. StockNews.com cut shares of Edap Tms from a “hold” rating to a “sell” rating in a research note on Friday, April 19th. HC Wainwright upped their price target on shares of Edap Tms from $16.00 to $19.00 and gave the stock a “buy” rating in a research note on Monday, April 1st.

Edap Tms Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.